Lipoprotein(a) is Independently Associated with Polyvascular Disease Burden
Measuring lipoprotein(a) levels may help doctors better assess how much cardiovascular disease someone has across their whole body.
AIMS: Lipoprotein(a) [Lp(a)] is an established, genetically determined risk factor for atherosclerotic cardiovascular disease. CONCLUSIONS: Higher Lp(a) concentrations were independently associated with an increased polyvascular disease burden, suggesting that Lp(a) may reflect the extent of cardiovascular disease involvement across multiple disease domains.
What the study was
- Study design
- Observational/Cohort Study
- Population
- AIMS: Lipoprotein(a) [Lp(a)] is an established, genetically determined risk factor for atherosclerot
- Sample size
- 1799
- Category
- Prevention
- Maturity
- Validated
- Journal
- Journal of atherosclerosis and thrombosis
Why it surfaced
moderate relevance to watchlist
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.